Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.070
+0.040 (3.88%)
At close: Jun 2, 2026, 4:00 PM EDT
1.115
+0.045 (4.21%)
Pre-market: Jun 3, 2026, 7:33 AM EDT
Health In Tech Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Health In Tech stock has a consensus rating of "Buy" and an average price target of $4.03. The average 1-year stock price forecast is 276.64% higher than the current stock price, while the lowest is $4.00 (+273.83%) and the highest is $4.10 (+283.18%).
Price Target: $4.03 (+276.64%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Health In Tech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $4 | Buy | Reiterates | $4 | +273.83% | May 14, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $4 | Buy | Reiterates | $4 | +273.83% | May 14, 2026 |
Financial Forecast
Revenue This Year
46.81M
from 33.33M
Increased by 40.45%
Revenue Next Year
78.52M
from 46.81M
Increased by 67.75%
EPS This Year
-0.06
from 0.02
EPS Next Year
0.13
from -0.06
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 47.8M | |
| Avg | 46.8M | |
| Low | 46.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 43.5% | |
| Avg | 40.5% | |
| Low | 37.9% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.03 | |
| Avg | -0.06 | |
| Low | -0.10 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.